Glucosamine/Chondroitin
158 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
158
Total Reports
29
Deaths Reported
1840.0%
Death Rate
Active Ingredients
Glucosamine/Chondroitin
Administration Routes
UnknownOral
Species Affected
Dog 145
Cat 13
Most Affected Breeds
Retriever - Labrador 26
Retriever - Golden 18
Domestic Shorthair 11
Shepherd Dog - German 7
Terrier - Bull - American Pit 6
Boxer (German Boxer) 5
Collie - Border 5
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 5
Crossbred Canine/dog 3
Rottweiler 3
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 27
Vomiting 23
Death by euthanasia 21
Anorexia 17
Elevated alanine aminotransferase (ALT) 17
Weight loss 16
Other abnormal test result NOS 15
Panting 14
Diarrhoea 13
Polydipsia 13
Behavioural disorder NOS 11
Not eating 11
Outcome Breakdown
Ongoing
74 (46.8%)
Outcome Unknown
28 (17.7%)
Recovered/Normal
26 (16.5%)
Euthanized
21 (13.3%)
Died
8 (5.1%)
Recovered with Sequela
1 (0.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.